Hypertension is extremely common in patients on peritoneal dialysis (PD), with a prevalence of more than 80%. Moreover, refractory hypertension accounts for the increasing incidence of stroke and cardiovascular events which are the leading causes for death and peritoneal dialysis dropout. The 2015 International Society of Peritoneal Dialysis cardiovascular and metabolic guidelines for adult peritoneal dialysis patients recommended that the target of blood pressure in continuous ambulatory PD patients should be <140 mmHg systolic and <90 mmHg diastolic, irrespective of age. There are various factors that contribute to the poor control of hypertension in PD patients, of which hypervolumia and reduced residual renal function are the most common ones. Therapeutic strategies for blood pressure management in PD patients include 5 aspects: appropriate assessment on volume status, effective protection of residual renal function, flexible adjustment of dialysis prescription, right choice of anti-hypertensive drugs, and patient-centered team management.